Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Vaziri Gohar

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Molecular and Cellular Endocrinology|December 23, 2015
GPER1-mediated IGFBP-1 induction modulates IGF-1-dependent signaling in tamoxifen-treated breast cancer cellsAli Vaziri-Gohar, Kevin D Houston
Molecular Cancer Research : MCR|January 19, 2017
IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer CellsAli Vaziri-Gohar, Yan Zheng, Kevin D Houston
Frontiers in Oncology|January 12, 2019
Metabolic Dependencies in Pancreatic CancerAli Vaziri-Gohar, Mahsa Zarei, Jonathan R Brody, et al.
Frontiers in Oncology|February 27, 2019
Corrigendum: Metabolic Dependencies in Pancreatic CancerAli Vaziri-Gohar, Mahsa Zarei, Jonathan R Brody, et al.
Biomedical Optics Express|September 7, 2013
Subcellular localization-dependent changes in EGFP fluorescence lifetime measured by time-resolved flow cytometryAli Vaziri Gohar, Ruofan Cao, Patrick Jenkins, et al.
Molecular Cancer Research : MCR|September 30, 2018
RNA-Binding Protein HuR Regulates Both Mutant and Wild-Type IDH1 in IDH1-Mutated CancerMahsa Zarei, Shruti Lal, Ali Vaziri-Gohar, et al.
American Journal of Cancer Research|October 17, 2024
A novel NR4A2-HuR axis promotes pancreatic cancer growth and tumorigenesis that is inhibited by NR4A2 antagonistsSneha Johnson, Zuhua Yu, Xi Li, et al.
Cancer Research Communications|May 18, 2022
Nuclear Receptor 4A2 (NR4A2/NURR1) Regulates Autophagy and Chemoresistance in Pancreatic Ductal AdenocarcinomaMehrdad Zarei, Rupesh Shrestha, Sneha Johnson, et al.
Molecular Cancer Therapeutics|October 3, 2022
IDO1 Is a Therapeutic Target for Pancreatic Cancer-Associated DepressionJonathan J Hue, Hallie J Graor, Mehrdad Zarei, et al.
Journal of Cancer Science and Clinical Therapeutics|January 16, 2023
Liver Endothelium Microenvironment Promotes HER3-mediated Cell Growth in Pancreatic Ductal AdenocarcinomaMoeez Rathore, Wei Zhang, Michel'le Wright, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Molecular and Cellular Endocrinology|December 23, 2015
GPER1-mediated IGFBP-1 induction modulates IGF-1-dependent signaling in tamoxifen-treated breast cancer cellsAli Vaziri-Gohar, Kevin D Houston
Molecular Cancer Research : MCR|January 19, 2017
IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer CellsAli Vaziri-Gohar, Yan Zheng, Kevin D Houston
Frontiers in Oncology|January 12, 2019
Metabolic Dependencies in Pancreatic CancerAli Vaziri-Gohar, Mahsa Zarei, Jonathan R Brody, et al.
Frontiers in Oncology|February 27, 2019
Corrigendum: Metabolic Dependencies in Pancreatic CancerAli Vaziri-Gohar, Mahsa Zarei, Jonathan R Brody, et al.
Biomedical Optics Express|September 7, 2013
Subcellular localization-dependent changes in EGFP fluorescence lifetime measured by time-resolved flow cytometryAli Vaziri Gohar, Ruofan Cao, Patrick Jenkins, et al.
Molecular Cancer Research : MCR|September 30, 2018
RNA-Binding Protein HuR Regulates Both Mutant and Wild-Type IDH1 in IDH1-Mutated CancerMahsa Zarei, Shruti Lal, Ali Vaziri-Gohar, et al.
American Journal of Cancer Research|October 17, 2024
A novel NR4A2-HuR axis promotes pancreatic cancer growth and tumorigenesis that is inhibited by NR4A2 antagonistsSneha Johnson, Zuhua Yu, Xi Li, et al.
Cancer Research Communications|May 18, 2022
Nuclear Receptor 4A2 (NR4A2/NURR1) Regulates Autophagy and Chemoresistance in Pancreatic Ductal AdenocarcinomaMehrdad Zarei, Rupesh Shrestha, Sneha Johnson, et al.
Molecular Cancer Therapeutics|October 3, 2022
IDO1 Is a Therapeutic Target for Pancreatic Cancer-Associated DepressionJonathan J Hue, Hallie J Graor, Mehrdad Zarei, et al.
Journal of Cancer Science and Clinical Therapeutics|January 16, 2023
Liver Endothelium Microenvironment Promotes HER3-mediated Cell Growth in Pancreatic Ductal AdenocarcinomaMoeez Rathore, Wei Zhang, Michel'le Wright, et al.
Pageof 3